Women across the United States are signing up for the Depo-Provera lawsuit after research linked the injectable birth control to a serious type of brain tumor called meningioma. If you used Depo-Provera and later developed a brain tumor, you may have legal grounds for compensation in 2026.
This guide covers everything you need to know. Who qualifies. How much you could receive. What documents you need. And exactly how the sign-up process works.
The litigation has grown rapidly. Hundreds of cases have already been consolidated into a federal multidistrict litigation docket. Time-sensitive filing deadlines make 2026 a critical year for anyone who believes they were harmed.
Read this front to back. By the end, you will know whether you have a case and what your next step should be.
How to Sign Up for the Depo-Provera Lawsuit in 2026
Signing up for the Depo-Provera lawsuit means contacting a mass tort attorney who is actively filing claims in MDL 3140, the federal multidistrict litigation handling these cases.
The process is not complicated. Most law firms handling Depo-Provera cases offer a free case evaluation. You speak with someone, share your medical and prescription history, and they determine whether your situation meets the legal threshold.
Here is what the general sign-up process looks like:
| Step | What Happens |
|---|---|
| Step 1: Initial Contact | You reach out to a mass tort law firm handling Depo-Provera claims |
| Step 2: Free Evaluation | A legal intake specialist reviews your medical and usage history |
| Step 3: Document Gathering | You collect medical records, prescription history, and diagnosis paperwork |
| Step 4: Retainer Agreement | You sign a contingency fee agreement (no upfront cost) |
| Step 5: Case Filed | Your attorney files your individual claim within the MDL |
The sign-up itself takes anywhere from 20 minutes to a couple of hours depending on how organized your records are.
Most attorneys work on contingency. That means they only get paid if you win or settle. You pay nothing out of pocket to get started.
Key deadline alert: Statutes of limitations vary by state. Many run 2 to 3 years from the date of diagnosis or discovery. In 2026, some early claimants are already approaching their cutoff.
Who Qualifies for the Depo-Provera Lawsuit?
The women who qualify for the Depo-Provera lawsuit are those who used the injectable contraceptive for an extended period and later received a diagnosis of intracranial meningioma.
That is the core profile. But there are several layers to it.
You do not need to have had brain surgery to qualify. Even if your meningioma was treated with radiation or simply monitored, you may still have a valid claim.
General qualifying profile:
- Used Depo-Provera (medroxyprogesterone acetate) as a contraceptive injection
- Received injections over a prolonged period (typically one year or more)
- Received a diagnosis of intracranial meningioma confirmed by imaging or biopsy
- Diagnosis came during or after the period of Depo-Provera use
Women who used the drug for shorter periods may still qualify depending on dosage and other medical factors.
| Qualifying Factor | Typical Requirement |
|---|---|
| Drug Used | Depo-Provera (injectable MPA) |
| Duration of Use | Generally 12+ months of use |
| Diagnosis Required | Intracranial meningioma |
| Proof Needed | Medical records + prescription history |
| Age at Diagnosis | No strict age limitation |
Family members of women who died from meningioma after using Depo-Provera may also qualify to file a wrongful death claim.
What Are the Depo-Provera Lawsuit Eligibility Requirements?
The formal eligibility requirements for the Depo-Provera lawsuit go beyond just “I used the shot and got a brain tumor.”
Attorneys and courts are looking for a documented causal link between the drug use and the diagnosis. That means your medical records need to show a timeline that connects the two.
Core eligibility checklist:
- Confirmed Depo-Provera use with pharmacy or medical records
- Meningioma diagnosis confirmed by MRI, CT scan, or surgical pathology report
- Diagnosis occurred during use or within a reasonable period after use
- No prior history of meningioma before starting Depo-Provera (or a documented change in tumor status after use began)
- Claim filed within your state’s statute of limitations
Some attorneys are also evaluating cases involving women who used generic medroxyprogesterone acetate injections, not just the branded Depo-Provera product.
Think of eligibility like a three-legged stool. You need proof of use, proof of diagnosis, and proof of timing. Remove any one of those legs and the case gets harder to stand.
Bold stat: According to a 2023 French study published in the British Medical Journal, women who used injectable progestins like Depo-Provera for more than one year faced a roughly 5.6 times greater risk of developing intracranial meningioma compared to non-users.
Key Takeaway: To qualify for the Depo-Provera lawsuit, you generally need documented use of the injection for at least 12 months and a confirmed meningioma diagnosis supported by medical imaging records.
What Is the Depo-Provera Brain Tumor Lawsuit About?
The Depo-Provera brain tumor lawsuit centers on one central allegation: Pfizer knew or should have known that their injectable contraceptive significantly raised the risk of meningioma, and they failed to warn patients and doctors about that risk.
That failure to warn is what drives the legal theory. In product liability law, a manufacturer has a duty to disclose known risks. Plaintiffs argue Pfizer did not live up to that duty.
Meningioma is a tumor that forms on the membranes surrounding the brain and spinal cord. Most meningiomas are non-cancerous (benign), but they can still cause life-altering harm.
When a meningioma grows large enough, it can cause severe headaches, vision loss, hearing problems, seizures, memory loss, and personality changes. Surgery to remove one carries serious risks including stroke, infection, and permanent neurological damage.
For many women, the diagnosis came years after they stopped using Depo-Provera. They had no idea the drug they trusted for birth control was silently raising their cancer risk.
Timeline of key events:
| Year | Event |
|---|---|
| 1992 | FDA approves Depo-Provera as a contraceptive in the United States |
| 2023 | Major French BMJ study links injectable MPA to meningioma risk |
| 2024 | U.S. lawsuits begin consolidating in federal court |
| Early 2025 | MDL 3140 formally established in the Southern District of Illinois |
| 2026 | Bellwether trials and early settlements expected |
What Is the Depo-Provera Meningioma Lawsuit?
The Depo-Provera meningioma lawsuit is the specific legal action targeting the link between the drug’s active ingredient, medroxyprogesterone acetate, and the development of intracranial meningiomas.
“Meningioma” is not just a scary medical word in this context. It is the specific tumor type that the science has identified as being elevated in Depo-Provera users.
The French ANSM study was the turning point. Researchers examined data from over 18,000 women in France and found a statistically significant increase in meningioma rates among women who used high-dose or long-term injectable progestins.
That study gave plaintiffs’ attorneys the scientific foundation they needed to take these cases to court.
Meningiomas tied to progestin use often grow in specific locations, particularly the skull base. Those locations make surgical removal especially dangerous and complex.
What the meningioma lawsuit specifically claims:
- Depo-Provera accelerates meningioma growth or triggers initial tumor formation
- Pfizer had access to European safety signals for years before U.S. action was taken
- The drug’s U.S. label did not adequately warn about meningioma risk
- Women who underwent surgery, radiation, or ongoing monitoring suffered real financial and personal harm
Is Pfizer Being Sued Over Depo-Provera?
Yes, Pfizer is the primary defendant in the Depo-Provera meningioma lawsuits, as the current manufacturer and marketer of the drug in the United States.
Pfizer acquired Pharmacia Corporation in 2003. Pharmacia had originally developed and marketed Depo-Provera. When Pfizer took over, it inherited both the product and the legal responsibilities that come with it.
Plaintiffs argue that as the drug’s owner and distributor, Pfizer had an obligation to monitor post-market safety signals, update labeling when new risks were identified, and communicate those risks to prescribing physicians and patients.
The European regulatory environment had already started raising flags about progestin-linked meningioma risks before the major 2023 study. French regulators had even restricted some progestin products in prior years.
Critics of Pfizer argue the company was slow to respond to mounting evidence. That delay forms a key part of the negligence argument in these lawsuits.
Pfizer lawsuit basics:
| Detail | Information |
|---|---|
| Defendant | Pfizer Inc. |
| Original Developer | Pharmacia Corporation |
| Drug at Issue | Depo-Provera (injectable MPA) |
| Legal Theory | Product liability, failure to warn |
| Court | U.S. District Court, Southern District of Illinois |
| MDL Docket | MDL 3140 |
What Side Effects Are Behind the Depo-Provera Lawsuit?
The side effect driving the Depo-Provera lawsuit is intracranial meningioma, a tumor of the brain’s protective membranes that can cause permanent, sometimes fatal harm.
This is not a lawsuit about common side effects like weight gain or irregular periods. Those side effects have long appeared on Depo-Provera’s label.
Meningioma was not prominently or clearly disclosed as a risk to U.S. patients. That is the legal crux.
Women affected describe a range of serious symptoms that ultimately led to their meningioma diagnosis:
- Chronic severe headaches that do not respond to over-the-counter treatment
- Progressive vision changes or double vision
- Hearing loss or ringing in the ears
- Weakness or numbness in the arms or legs
- Seizures with no prior history
- Cognitive changes including memory problems and mood shifts
Many of these symptoms were misattributed to stress, migraines, or other conditions for months or years before a brain scan revealed the actual cause.
The delayed discovery problem: Because meningiomas grow slowly, women often do not develop noticeable symptoms until the tumor reaches a significant size. By then, treatment options may be limited or particularly risky.
Key Takeaway: The Depo-Provera lawsuit focuses specifically on meningioma, a type of brain tumor that plaintiffs allege Pfizer failed to warn them about despite growing scientific evidence linking the drug to this risk.
What Are the Long-Term Side Effects of Depo-Provera?
Depo-Provera’s long-term side effects include bone density loss, prolonged fertility delays, and, most critically for this litigation, an elevated risk of intracranial meningioma with extended use.
The bone density issue has been on the label for years. The FDA added a black box warning about that specific risk in 2004.
But meningioma risk from long-term use only became clearly documented in recent research. The longer a woman used Depo-Provera, the more the data suggests the risk compounds.
Women who used the injection for three years or more appear to have the highest risk profiles in the current studies.
Long-term side effects documented in research and litigation:
| Side Effect | Documentation Status |
|---|---|
| Bone density loss (osteoporosis risk) | FDA black box warning since 2004 |
| Prolonged return to fertility | Listed on label |
| Irregular or absent periods | Listed on label |
| Intracranial meningioma | Not adequately disclosed; central to lawsuit |
| Mood changes and depression | Partially listed |
The long-term meningioma risk is particularly alarming because the drug is widely used by younger women. Many users started Depo-Provera in their teens or twenties and continued for years.
Is the Depo-Provera Lawsuit a Class Action?
The Depo-Provera lawsuit is not a traditional class action. It is structured as a mass tort consolidated into a multidistrict litigation (MDL).
The distinction matters and many people get this wrong.
In a class action, everyone is grouped into one case with one shared settlement amount. In a mass tort MDL, each plaintiff has their own individual case. Each person can receive compensation based on their own specific injuries and circumstances.
That structure actually tends to benefit claimants with serious injuries like brain tumors. A woman who required three surgeries is not lumped together with someone who had a single imaging procedure.
Class Action vs. MDL Comparison:
| Feature | Class Action | MDL (Depo-Provera) |
|---|---|---|
| Cases Combined? | Yes, into one | Yes, for pretrial efficiency |
| Individual Damages? | Shared equally | Based on individual injury |
| Better for Serious Injuries? | No | Yes |
| Can Opt Out? | Usually yes | Automatic individual case |
| Settlement Structure | One pot split | Individual settlements |
The Depo-Provera MDL allows for “bellwether trials,” where a small number of cases go to trial first. The outcomes of those trials help both sides estimate the value of remaining cases and often push toward global settlement negotiations.
Depo-Provera MDL Lawsuit Update 2026
As of 2026, the Depo-Provera litigation is centralized in MDL 3140, pending in the U.S. District Court for the Southern District of Illinois.
The MDL was formally established in early 2025 after judges determined the cases were too numerous and legally complex to be handled efficiently in different courts across the country.
Centralization means that discovery, expert witness designations, and pretrial motions are handled in one court for all plaintiffs. It is more efficient and more consistent.
By late 2025 into 2026, the court was in the discovery phase. That is when both sides exchange evidence, medical records, internal company documents, and expert reports.
MDL 3140 Timeline:
| Phase | Timeframe |
|---|---|
| MDL Formation | Early 2025 |
| Discovery Phase | Mid 2025 to Late 2026 |
| Bellwether Trial Selection | Expected Late 2026 |
| First Bellwether Trials | Potentially 2027 |
| Global Settlement Talks | Likely to accelerate 2026 to 2027 |
New cases continue to be added to the MDL. If you have not filed yet, your claim can still be included in the MDL as the litigation progresses.
Key Takeaway: The Depo-Provera MDL is actively progressing through 2026, with discovery underway and bellwether trials expected to begin shaping settlement negotiations in the near future.
What Is the Current Status of the Depo-Provera Lawsuit in 2026?
The Depo-Provera lawsuit is in an active and growing phase as of 2026, with the MDL accumulating new plaintiffs while early pretrial proceedings shape the legal framework for the entire litigation.
This is not a dormant or settled case. It is moving. That matters because the more active the MDL is, the more pressure builds on Pfizer to reach settlement agreements.
Pharmaceutical companies typically prefer to settle mass tort cases rather than face jury trials. Juries tend to award higher damages when they hear about a major corporation that failed to warn patients about a cancer risk.
In 2026, the major legal developments to watch include:
- Expert witness designations: Both sides present scientific experts to establish or challenge the MPA-meningioma link
- Case Management Orders: The court sets schedules for discovery deadlines, motion practice, and trial dates
- Bellwether case selection: A small group of representative cases will be selected for early trials
- Settlement discussions: As evidence matures, both sides begin informal valuation talks
If you are not already in the MDL, 2026 is still a viable window to file. But that window is not unlimited.
How to File a Depo-Provera Lawsuit Step by Step
Filing a Depo-Provera lawsuit involves contacting a qualified mass tort attorney, gathering your medical and prescription documentation, and having your case submitted to the MDL docket.
Here is the process broken down simply:
Step 1: Confirm your usage history
Locate any records showing you received Depo-Provera injections. Pharmacy records, insurance claims, OB-GYN records, and hospital charts all count.
Step 2: Obtain your meningioma diagnosis records
Your MRI or CT scan reports, surgical pathology reports, and any treating neurologist or neurosurgeon records are critical. Get them now if you do not already have copies.
Step 3: Contact a mass tort law firm
Find a firm that specifically handles Depo-Provera cases and is actively filing in MDL 3140. The initial consultation is free at most reputable firms.
Step 4: Complete your intake evaluation
The firm will ask about your usage timeline, diagnosis date, treatments received, and any ongoing medical needs.
Step 5: Sign a contingency agreement
You pay nothing upfront. The attorney’s fee comes from your eventual settlement or verdict.
Step 6: Your case is filed
Your attorney prepares and files a Short Form Complaint within the MDL. Your case becomes part of the litigation.
| Document | Why It Matters |
|---|---|
| Prescription or injection records | Proves you used Depo-Provera |
| Insurance EOBs showing Depo-Provera | Secondary proof of usage |
| MRI/CT scan reports | Confirms meningioma diagnosis |
| Surgical or pathology report | Strongest diagnostic proof |
| Neurologist treatment records | Shows extent of harm |
| Bills and medical expenses | Supports economic damages claim |
What Is the Depo-Provera Lawsuit Filing Deadline in 2026?
The filing deadline for a Depo-Provera lawsuit depends on your state’s statute of limitations, which typically runs two to three years from the date you discovered or reasonably should have discovered the connection between your meningioma and Depo-Provera use.
That “discovery rule” is important. Many women were diagnosed with meningioma without anyone telling them Depo-Provera might have caused it. The clock in many states does not start until you knew or reasonably could have known about the link.
But do not count on that protection indefinitely.
Statute of limitations by state type:
| State Category | Typical Limitation Period |
|---|---|
| Two-year states | 2 years from discovery |
| Three-year states | 3 years from discovery |
| States with discovery rule | Clock starts at date of knowledge |
| States with absolute outer limits | 10 years from last drug use (varies) |
Waiting too long is the single biggest mistake injured plaintiffs make. Once your statute of limitations expires, no court can hear your case. Not even if your injuries are severe and well-documented.
If you were diagnosed with meningioma and used Depo-Provera at any point in the past decade, 2026 may be your final viable window in many states.
Key Takeaway: Filing deadlines for the Depo-Provera lawsuit are state-specific and unforgiving. The safest move is to consult a mass tort attorney in 2026 rather than assume you have more time.
How Much Compensation Can You Get from the Depo-Provera Lawsuit?
Compensation in the Depo-Provera lawsuit can range from tens of thousands of dollars to potentially millions, depending on the severity of your meningioma diagnosis, the treatment required, and the lasting impact on your life.
No official settlement has been finalized as of 2026. The MDL is still in earlier stages. But mass tort attorneys and legal analysts have begun offering early valuation estimates based on similar pharmaceutical litigation outcomes.
The compensation categories in a Depo-Provera claim typically include:
- Economic damages: Medical bills, surgical costs, hospital stays, ongoing treatment, lost income
- Non-economic damages: Pain and suffering, loss of quality of life, emotional distress
- Punitive damages: Possible in cases where a jury finds Pfizer’s conduct particularly egregious
Think of compensation tiers like the rings of a dartboard. The closer your case sits to the center of maximum harm, the higher your potential payout.
Estimated compensation ranges (pre-settlement, illustrative):
| Injury Severity | Estimated Range |
|---|---|
| Diagnosed, no surgery required | $50,000 to $150,000 |
| Surgery required, full recovery | $150,000 to $500,000 |
| Surgery with permanent deficits | $500,000 to $1,500,000 |
| Severe disability or fatal outcome | $1,000,000 to $3,000,000+ |
These are estimates only, based on similar mass tort litigation. Final amounts will depend on MDL outcomes, bellwether trial results, and global settlement negotiations.
What Is the Depo-Provera Settlement Amount?
No final Depo-Provera settlement amount has been officially announced as of 2026, because the litigation is still in progress and no global resolution has been reached.
That is not unusual. Most major pharmaceutical mass torts take three to seven years from consolidation to global settlement. The Depo-Provera MDL is still in its early-to-middle phase.
For context, looking at comparable cases helps set realistic expectations.
Comparable pharmaceutical mass tort settlements:
| Case | Product | Approximate Settlement | Key Similarity |
|---|---|---|---|
| Essure IUD Cases | Bayer Essure | $1.6 billion (2020) | Device injury, women’s health |
| Risperdal Gynecomastia | Johnson and Johnson | $800 million+ | Failure to warn, hormonal drug |
| Taxotere Hair Loss | Sanofi | Ongoing, individual verdicts $10M+ | Pharmaceutical side effect, cancer adjacent |
| Mirena IUD | Bayer | Settled confidentially | Hormonal device, brain pressure link |
These comparisons suggest the Depo-Provera litigation could result in a substantial global settlement once bellwether trials establish the value of individual claims.
When a settlement is reached, the court will appoint a settlement administrator. Every claimant with a filed case will be notified. Filing now ensures you are in the pool when that happens.
What Could Your Depo-Provera Lawsuit Payout Look Like?
Your individual Depo-Provera lawsuit payout will be shaped by several specific factors related to your own medical experience, financial losses, and the overall trajectory of the MDL.
Attorneys evaluate individual cases using what is called a point system or tier matrix in many mass torts. Higher-severity cases earn more points, which translate to higher payouts.
Factors that increase your payout:
- Multiple surgeries required
- Permanent neurological deficits (vision loss, hearing loss, cognitive impairment)
- Younger age at diagnosis (more years of suffering, longer earning capacity affected)
- Large tumor requiring complex surgery
- Recurrent meningioma after initial treatment
- Death resulting from meningioma or surgical complications
Factors that may reduce your payout:
- Very short period of Depo-Provera use
- Pre-existing meningioma diagnosis before drug use began
- Prior history of conditions known to cause meningioma independently
- Missing or incomplete medical records
| Payout Factor | Effect on Claim Value |
|---|---|
| Cranial surgery with complications | Significantly increases value |
| Permanent disability documented | Major increase |
| Documented income loss | Increases economic damages |
| Strong medical record chain | Strengthens overall claim |
| Generic MPA use vs. brand name | May slightly complicate claim |
| State statute of limitations compliance | Required for any payout |
The single most important thing you can do right now is preserve every piece of medical documentation you have. Records age out of electronic systems. Providers retire or close. Your paper trail is your proof.
Key Takeaway: Your Depo-Provera lawsuit payout depends heavily on the severity of your meningioma and how well-documented your medical and prescription history is, making record preservation a priority action right now.
Frequently Asked Questions
How do I sign up for the Depo-Provera lawsuit?
You sign up by contacting a mass tort law firm that is actively filing claims in MDL 3140.
The firm will conduct a free case evaluation to verify your Depo-Provera use and meningioma diagnosis.
Once you qualify, your attorney files a Short Form Complaint on your behalf within the federal MDL.
What medical diagnosis do I need to file a Depo-Provera lawsuit?
An intracranial meningioma diagnosis confirmed by MRI, CT scan, or surgical pathology report is the primary medical requirement.
The diagnosis must be connected to your documented use of Depo-Provera or generic injectable medroxyprogesterone acetate.
Cases involving other brain tumor types or conditions unrelated to MPA are generally not included in the current MDL.
How much money can I get from a Depo-Provera brain tumor settlement?
Individual payouts in similar mass torts have ranged from $50,000 for minor diagnosed cases to over $2 million for cases involving surgery, permanent disability, or death.
No official settlement amounts have been confirmed as of 2026, as negotiations are still in early stages.
Your actual payout will depend on your specific medical history, treatment costs, and the final terms negotiated in the MDL.
What is the deadline to file a Depo-Provera lawsuit in 2026?
There is no single universal deadline. Each state has its own statute of limitations, typically two to three years from the date you knew or should have known about the Depo-Provera and meningioma connection.
For many women diagnosed between 2022 and 2024, the 2026 calendar year may represent the final window to file in strict-deadline states.
Getting a case evaluation immediately is the safest way to protect your right to compensation.
Does it cost anything to sign up for the Depo-Provera lawsuit?
Signing up costs nothing upfront because mass tort attorneys work on a contingency fee basis.
You pay zero attorney fees unless your case results in a settlement or verdict in your favor.
The contingency fee is typically 33 to 40 percent of your recovery, which is standard in personal injury and mass tort litigation.
Your Next Step in 2026
The Depo-Provera lawsuit is one of the most significant women’s health mass torts in recent years. The science is solid. The litigation is moving. And the compensation for qualifying claimants could be substantial.
If you used Depo-Provera and received a meningioma diagnosis, you have real legal options in 2026. Gather your medical records now. Do not wait on your state’s filing deadline.
Contact a mass tort attorney who handles Depo-Provera cases, confirm your eligibility, and get your case filed. Every day you wait is a day closer to a deadline that cannot be undone.
